Tachycardia-Induced Cardiomyopathy in an Infant with Atrial Flutter and Prolonged Recovery of Cardiac Function.
Tomohide SakaiKaori TsuboiShinya TakaradaMako OkabeHideyuki NakaokaKeijiro IbukiSayaka W OzawaYukiko HataShojiro IchimataNaoki NishidaKeiichi HironoPublished in: Journal of clinical medicine (2024)
Background: Tachycardia-induced cardiomyopathy (TIC) is caused by prolonged tachycardia, leading to left ventricular dilatation and systolic dysfunction with heart failure. Although TIC is more common in adults, it is rare in early infancy. Methods: Clinical testing was performed as part of medical evaluation and management. Next-generation sequencing (NGS) was conducted for a patient with TIC. A literature review on TIC was also conducted. Results: The case involved a 5-month-old infant referred to the hospital due to symptoms of heart failure lasting at least two months. The infant's heart rate was 200 beats per minute, the left ventricular ejection fraction fell below 14%, and electrocardiograms showed atrial flutter, suggesting TIC. After cardioversion, there was no recurrence of atrial flutter, and cardiac function improved 98 days after tachycardia arrest. The NGS did not identify any pathogenic variants. The literature review identified eight early infantile cases of TIC. However, no previous reports described a case with such a prolonged duration of TIC as ours. Conclusions: This is the first report of a case of prolonged TIC in a child with the documented time to recover normal cardiac function. The improvement of cardiac function depends on the duration of TIC. Early recognition and intervention in TIC are essential to improve outcomes for infantile patients, as timely treatment offers the potential for recovery.
Keyphrases
- obsessive compulsive disorder
- heart failure
- catheter ablation
- atrial fibrillation
- left ventricular
- ejection fraction
- left atrial
- heart rate
- aortic stenosis
- deep brain stimulation
- case report
- randomized controlled trial
- cardiac resynchronization therapy
- end stage renal disease
- mitral valve
- chronic kidney disease
- heart rate variability
- oxidative stress
- gene expression
- diabetic rats
- newly diagnosed
- climate change
- drug induced
- adverse drug
- patient reported outcomes
- acute coronary syndrome
- risk assessment
- physical activity
- percutaneous coronary intervention
- transcatheter aortic valve replacement
- smoking cessation